Literature DB >> 31764671

New Insights on Lipedema: The Enigmatic Disease of the Peripheral Fat.

Anna-Theresa Bauer1, Dominik von Lukowicz, Katrin Lossagk, Matthias Aitzetmueller, Philipp Moog, Michael Cerny, Holger Erne, Daniel Schmauss, Dominik Duscher, Hans-Guenther Machens.   

Abstract

BACKGROUND: Although a large number of adult women worldwide are affected by lipedema, the physiologic conditions triggering onset and progression of this chronic disease remain enigmatic. In the present study, a descriptive epidemiologic situation of postoperative lipedema patients is presented.
METHODS: The authors developed an online survey questionnaire for lipedema patients in Germany. The survey was conducted on 209 female patients who had been diagnosed with lipedema and had undergone tumescent liposuction.
RESULTS: Most of the participants (average age, 38.5 years) had noticed a first manifestation of the disease at the age of 16. It took a mean of 15 years to accomplish diagnosis. Liposuction led to a significant reduction of pain, swelling, tenderness, and easy bruising as confirmed by the majority of patients. Hypothyroidism [n = 75 (35.9 percent) and depression [n = 48 (23.0 percent)] occurred at a frequency far beyond the average prevalence in the German population. The prevalence of diabetes type 1 [n = 3 (1.4 percent)], and diabetes type 2 [n = 2 (1 percent)] was particularly low among the respondents. Forty-seven of the lipedema patients (approximately 22.5 percent) suffered from a diagnosed migraine. Following liposuction, the frequency and/or intensity of migraine attacks became markedly reduced, as stated by 32 patients (68.1 percent).
CONCLUSIONS: Quality of life increases significantly after surgery with a reduction of pain and swelling and decreased tendency to easy bruising. The high prevalence of hypothyroidism in lipedema patients could be related to the frequently observed lipedema-associated obesity. The low prevalence of diabetes, dyslipidemia, and hypertension appears to be a specific characteristic distinguishing lipedema from lifestyle-induced obesity.

Entities:  

Mesh:

Year:  2019        PMID: 31764671     DOI: 10.1097/PRS.0000000000006280

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  9 in total

1.  Characteristics and Patient Reported Outcome Measures in Lipedema Patients-Establishing a Baseline for Treatment Evaluation in a High-Volume Center.

Authors:  Matthias Hamatschek; Henning Knors; Marie-Luise Klietz; Philipp Wiebringhaus; Matthias Aitzetmueller; Tobias Hirsch; Maximilian Kueckelhaus
Journal:  J Clin Med       Date:  2022-05-17       Impact factor: 4.964

Review 2.  Lipedema-Pathogenesis, Diagnosis, and Treatment Options.

Authors:  Philipp Kruppa; Iakovos Georgiou; Niklas Biermann; Lukas Prantl; Peter Klein-Weigel; Mojtaba Ghods
Journal:  Dtsch Arztebl Int       Date:  2020-06-01       Impact factor: 5.594

3.  Common and Contrasting Characteristics of the Chronic Soft-Tissue Pain Conditions Fibromyalgia and Lipedema.

Authors:  Felix Angst; Thomas Benz; Susanne Lehmann; Peter Sandor; Stephan Wagner
Journal:  J Pain Res       Date:  2021-09-17       Impact factor: 3.133

4.  A Multi-Gene Panel to Identify Lipedema-Predisposing Genetic Variants by a Next-Generation Sequencing Strategy.

Authors:  Sandro Michelini; Karen L Herbst; Vincenza Precone; Elena Manara; Giuseppe Marceddu; Astrit Dautaj; Paolo Enrico Maltese; Stefano Paolacci; Maria Rachele Ceccarini; Tommaso Beccari; Elisa Sorrentino; Barbara Aquilanti; Valeria Velluti; Giuseppina Matera; Lucilla Gagliardi; Giacinto Abele Donato Miggiano; Matteo Bertelli
Journal:  J Pers Med       Date:  2022-02-11

Review 5.  A Scoping Review of Available Tools in Measurement of the Effectiveness of Conservative Treatment in Lipoedema.

Authors:  Monika Czerwińska; Jacek Teodorczyk; Rita Hansdorfer-Korzon
Journal:  Int J Environ Res Public Health       Date:  2022-06-10       Impact factor: 4.614

6.  Aldo-Keto Reductase 1C1 (AKR1C1) as the First Mutated Gene in a Family with Nonsyndromic Primary Lipedema.

Authors:  Sandro Michelini; Pietro Chiurazzi; Valerio Marino; Daniele Dell'Orco; Elena Manara; Mirko Baglivo; Alessandro Fiorentino; Paolo Enrico Maltese; Michele Pinelli; Karen Louise Herbst; Astrit Dautaj; Matteo Bertelli
Journal:  Int J Mol Sci       Date:  2020-08-29       Impact factor: 5.923

7.  Rest/stress intradermal lymphoscintigraphy in diagnosis of lipedema.

Authors:  Girolamo Tartaglione; Giuseppe Visconti; Roberto Bartoletti; Francesco Pio Ieria; Marzia Salgarello
Journal:  World J Nucl Med       Date:  2020-06-27

8.  Management of Lipedema with Ketogenic Diet: 22-Month Follow-Up.

Authors:  Roberto Cannataro; Sandro Michelini; Lorenzo Ricolfi; Maria Cristina Caroleo; Luca Gallelli; Giovambattista De Sarro; Alberto Onorato; Erika Cione
Journal:  Life (Basel)       Date:  2021-12-15

9.  Standard of care for lipedema in the United States.

Authors:  Karen L Herbst; Linda Anne Kahn; Emily Iker; Chuck Ehrlich; Thomas Wright; Lindy McHutchison; Jaime Schwartz; Molly Sleigh; Paula Mc Donahue; Kathleen H Lisson; Tami Faris; Janis Miller; Erik Lontok; Michael S Schwartz; Steven M Dean; John R Bartholomew; Polly Armour; Margarita Correa-Perez; Nicholas Pennings; Edely L Wallace; Ethan Larson
Journal:  Phlebology       Date:  2021-05-28       Impact factor: 1.740

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.